AngioDynamics (ANGO)
(Delayed Data from NSDQ)
$6.40 USD
+0.26 (4.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $6.41 +0.01 (0.16%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth D Momentum B VGM
Price, Consensus and EPS Surprise
ANGO 6.40 +0.26(4.23%)
Will ANGO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ANGO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ANGO
AngioDynamics (ANGO) Loses -15.86% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise
ANGO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Add AngioDynamics Stock to Your Portfolio
AngioDynamics (ANGO) Reports Q1 Loss, Misses Revenue Estimates
Here's What Could Help AngioDynamics (ANGO) Maintain Its Recent Price Strength
Other News for ANGO
3 Stocks Insiders Are Buying Heavily In October 2024, And Why
Insider Buying: President and CEO James Clemmer Acquires Shares of AngioDynamics Inc (ANGO)
4 Analysts Assess AngioDynamics: What You Need To Know
AngioDynamics (ANGO) Gets a Buy from H.C. Wainwright
Wall Street Analysts Are Bullish on Top Healthcare Picks